Vascular dementia: Atherosclerosis, cognition and alzheimer's disease

Current Alzheimer Research

Volumn 8, Issue 4, 2011, Pages 341-344

  Obrien, R J ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Amyloid; Atherosclerosis; Dementia; Infarction

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BLOOD BRAIN BARRIER; BRAIN ATHEROSCLEROSIS; BRAIN CIRCULUS ARTERIOSUS; BRAIN DISEASE; BRAIN INFARCTION; CARDIOVASCULAR RISK; COGNITION; COGNITIVE RESERVE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HUMAN; MULTIINFARCT DEMENTIA; NERVE CELL PLASTICITY; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; SENILE PLAQUE; STROKE; WHITE MATTER; WHITE MATTER DISEASE;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN; COGNITION DISORDERS; DEMENTIA, VASCULAR; HUMANS; NEUROFIBRILLARY TANGLES; PLAQUE, AMYLOID;

EID: 79959337761     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720511795745267     Document Type: Article

References (57)

1. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277: 813-17 (1997).
2. Schneider JA, Wilson RS, Cochran EJ, Bienias JL, Arnold SE, Evans DA, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 60(7): 1082-8 (1997).
3. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 62: 1148-55 (2004).
4. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Ann Neurol 69(24): 2197-2204 (2007).
5. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354: 919-20 (1999).
6. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 977: 9-23 (2002).
7. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 62(4): 406-413 (2007).
8. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O'Brien RJ. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol 64(2): 168-76 (2008).
9. Vermeer SE, Longstreth WT, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 6(7): 611-9 (2007).
10. Geldmacher D. Office Diagnosis and Management of Alzheimer disease. Mediguide Geriatric Neurol 2(4): 23-36 (1998).
11. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348: 1215-22 (2003).
12. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study JAMA 277: 813-17 (1997).
13. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 62: 1148-55 (2004).
14. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cere-brovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354: 919-20 (1999).
15. MRC CFAS Pathological correlates of late onset dementia in a muticentre community based population in England and Wales. Lancet 357: 169-175 (2001).
16. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 977: 9-23 (2002).
17. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. 69(24): 2197-2204 (2007).
18. Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyket-sos C, et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 64: 1548-1552 (2005).
19. Liebetrau M, Steen B, Hamann GF, Skoog I. Silent and symptomatic infarcts on cranial computerized tomography in relation to dementia and mortality: a population-based study in 85-year-old subjects. Stroke 35(8): 1816-1820 (2004).
20. Suter O-C, Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K, et al. Cerebral hypoperfusion generates cortical watershed mi-croinfarcts in alzheimer disease. Stroke 33: 1986-1992 (2002).
21. Miklossy J. Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in alz-heimer's disease. Neurol Res 25: 605-610 (2003).
22. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 977: 9-23 (2002).
23. MRC CFAS Pathological correlates of late onset dementia in a muticentre community based population in England and Wales. Lancet 357: 169-175 (2001).
24. Riekse RG, Leverenz JB, McCormick W, Bowen JD, Teri L, Nochlin D, et al. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study. J Am Geriatr Soc 52(9): 1442-8 (2004).
25. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward?. Neurology 72(4): 368-74 (2009).
26. Exel EV, Gussekloo J, Houx P, de Craen AJM, Macfarlane PW, Bootsma-van der Wiel A, et al. Atherosclerosis and cognitive impairment are linked in the elderly. The Leiden 85- plus Study. Atherosclerosis 165: 353-359 (2002).
27. Sparks DL. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann NY Acad Sci 826: 128-46 (1997).
28. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's Disease: Inflammation, cholesterol, and misfolded proteins. Lancet 363: 1139-1146 (2004).
29. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3(3): 184-90 (2004).
30. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach, T. G. Atherosclerosis of cerebral arteries in Alzheimer Disease. Stroke 35, 2623-2627 (2004).
31. Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 64(3): 494-500 (2005).
32. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, et al. Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 23(11): 2055-62 (2003).
33. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, Har-skamp FV, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's Disease in the Rotterdam Study. Lancet 349,151-154 (1997).
34. Roher AE, Garami Z, Alexandrov AV, Kokjohn TA, Esh CL, Kalback WM, et al. Interaction of cardiovascular disease and neurode-generation: transcranial Doppler ultrasonography and Alzheimer's disease. Neurol Res 28(6): 672-8 (2006).
35. Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, et al. Circle of Willis atherosclerosis: Association with Alzheimer's Disease, neuritic plaques and neurofibrillary tangles. Acta Neuro-pathol 113, 13-21 (2007).
36. Driscoll I, Resnick SM, Troncoso JC, An Y, O'Brien R, Zonderman AB. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol 60(6): 688-95 (2006).
37. Dolan H, Crain B, Troncoso J, Resnick S, Zonderman A, OBrien R. Atherosclerosis, Dementia, and Alzheimer's Disease in the BLSA Cohort. Ann Neurol 68: 231-241 (2010).
38. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239-259 (1991).
39. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41(4): 479-86 (1991).
40. Itoh Y, Yamada M, Sodeyama N, Suematsu N, Matsushita M, Otomo E, et al. Atherosclerosis is not implicated in association of APOE e4with AD. Neurology 53, 236-238 (1999).
41. Jagust WJ, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol 63(1): 72-80 (2008).
42. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844 (2000).
43. D'Armiento FP, Bianchi A, de Nigris F, Capuzzi DM, D'Armiento MR, Crimi G, et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 32(11): 2472-9 (2001).
44. Frisoni GB, Galluzzi S, Pantoni L, Filippi M. The effect of white matter lesions on cognition in the elderly--small but detectable. Nat Clin Pract Neurol 3(11): 620-7 (2007).
45. Arenillas JF, Alvarez-Sabín J. Basic mechanisms in intracranial large-artery atherosclerosis: advances and challenges. Cerebrovasc Dis 20 Suppl 2: 75-83 (2005).
46. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis. Atherosclerosis 197(1): 326-32 (2008).
47. Maczurek A, Shanmugam K, Munch G. Inflammation and the redox- sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease. Ann NY Acad Sci 1126: 147-151 (2008).
48. Wollner L, McCarthy ST, Soper NDW, Macy DJ. Failure of cerebral autoregulation as a cause of brain dysfunction in the elderly. Br Med J 1: 1117-1118 (1979).
49. Benarroch EE. Neurovascular unit dysfunction: a vascular component of Alzheimer disease? Neurology 68(20): 1730-2 (2007).
50. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MMB. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study. Stroke 39: 2712-2719. (2008).
51. Bell RD, Zlokovic BV. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118(1): 103-13 (2009).
52. Aboyans V, Lacroix P, Criqui MH. Large and small vessels atherosclerosis: similarities and differences. Prog Cardiovasc Dis 50(2): 112-25 (2007).
53. O'Sullivan M. Leukoaraiosis. Pract Neurol 8(1): 26-38 (2008).
54. Zhang Y, Schuff N, Du AT, Rosen HJ, Kramer JH, Gorno-Tempini ML, et al. White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain 132: 2579-92 (2009).
55. Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, et al. Heterogeneity of white matter hyperintensi-ties in Alzheimer's disease: post-mortem quantitative MRI and neu-ropathology. Brain 131: 3286-98 (2008).
56. O'Brien RJ, Resnick SM, Zonderman AB, Ferrucci L, Crain BJ, Pletnikova O, et al. Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). J Alzheimers Dis 18(3): 665-75 (2009).
57. Forette, ML Seux, JA Staessen, Fovette F, Seux ML, Staesser JA, Thijs L, Brikenhager WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352: 1347-1351 (1998).